(Appendices 1-4 available in PDF)
FDA solicited the advice and opinions of scientific experts and the public throughout the conduct of this Listeria monocytogenes risk assessment. A summary of the dates, type of review activity, and participants is provided below.
| Date | Activity | Participants |
|---|---|---|
| January 1999 | Risk Assessment Team assembled | FDA and FSIS |
| May 1999 | Federal Register Notice; request for comments and for scientific data and information | Public |
| May 1999 | Federal Register Notice of public meeting; request for comments | Public |
| May 1999 | Public meeting (Chicago, IL) | NACMCF; public |
| August 1999 | Federal Register Notice of public meeting | Public; Federal Register Notice |
| September 1999 | Public meeting; request for comments on the risk assessment approach and assumptions (Washington, DC) | NACMCF; Public |
| December 1999 | Request for scientific review of draft risk assessment document | RAC members |
| December 1999 | Technical discussion of the draft risk assessment document | RAC annual meeting (closed) |
| December 1999 | Intensive review of model | FDA |
| March 2000 | Internal scientific review of draft document | Selected FDA risk managers |
| May 2000 | Technical review of document | Selected government experts and SGE's |
| May 2000 | Review of model and mathematics | Selected government experts and SGE's |
| May 2000 | Data verification | FDA quality assurance team |
| September/ October 2000 | Interagency review of draft document | FDA, FSIS, CDC |
| January 2001 | Federal Register Notice of Availability of draft risk assessment document for public review and comment (66FR 5515) | Public |
| March 2001 | Public meeting; presentation of assumptions, approach, and results of the risk assessment and request for comment (66FR 13544) | Public |
| March 2001 | 1st extension of public comment period (66 FR13545) | Public |
| May 2001 | 2nd extension of public comment period (66 FR 28181) | Public |
| July 2001 | Close of public comment period | |
| July 2001 toDecember 2002 | Review of public comments including newly available data | FDA and FSIS |
| April 2003 | Technical review of revised report and model | FDA and FSIS |
| 2003 | Federal Notice of Availability of revised risk assessment | Public |
| 2003 | Public meeting; presentation of revised risk assessment | Public |
| FDA= Food and Drug Administration FSIS= Food Safety and Inspection Service NACMCF = the National Advisory Committee on Microbiological Criteria for Foods. RAC = the U.S. government Interagency Risk Assessment Consortium CDC = Center for Disease Control and Prevention SGE = Special Government Employees | ||